Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Vaccine ; 25 Suppl 1: A18-23, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17531357

ABSTRACT

Although Neisseria meningitidis is a highly variable organism, most invasive disease is caused by a minority of genotypes. Hypervirulent lineages have been identified and their pandemic spread has been traced. During a longitudinal meningococcal colonization study in a district of northern Ghana clonal waves of carriage and disease were observed. Genetic diversification of genoclouds was analysed by pulsed field gel electrophoretic (PFGE) analysis of isolates from healthy carriers and from meningitis patients. Even during the limited time of persistence in the district, microevolution of the dominating genoclouds took place. Population genomic analyses are required to understand the genetic basis for the emergence of new lineages with epidemic potential, which is of crucial importance for the development of long-term global vaccination strategies against meningococcal disease.


Subject(s)
Genetic Variation , Meningitis, Meningococcal/epidemiology , Neisseria meningitidis/genetics , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Geography , Ghana/epidemiology , Humans , Meningitis, Meningococcal/immunology , Neisseria meningitidis/classification , Neisseria meningitidis/pathogenicity , Neisseria meningitidis, Serogroup A/classification , Neisseria meningitidis, Serogroup A/genetics , Neisseria meningitidis, Serogroup A/pathogenicity , Neisseria meningitidis, Serogroup W-135/classification , Neisseria meningitidis, Serogroup W-135/genetics , Neisseria meningitidis, Serogroup W-135/pathogenicity , Serotyping , Time Factors , Virulence
2.
PLoS Med ; 4(3): e101, 2007 Mar 27.
Article in English | MEDLINE | ID: mdl-17388665

ABSTRACT

BACKGROUND: The Kassena-Nankana District of northern Ghana lies in the African "meningitis belt" where epidemics of meningococcal meningitis have been reoccurring every eight to 12 years for the last 100 years. The dynamics of meningococcal colonisation and disease are incompletely understood, and hence we embarked on a long-term study to determine how levels of colonisation with different bacterial serogroups change over time, and how the patterns of disease relate to such changes. METHODS AND FINDINGS: Between February 1998 and November 2005, pharyngeal carriage of Neisseria meningitidis in the Kassena-Nankana District was studied by twice-yearly colonisation surveys. Meningococcal disease was monitored throughout the eight-year study period, and patient isolates were compared to the colonisation isolates. The overall meningococcal colonisation rate of the study population was 6.0%. All culture-confirmed patient isolates and the majority of carriage isolates were associated with three sequential waves of colonisation with encapsulated (A ST5, X ST751, and A ST7) meningococci. Compared to industrialised countries, the colonising meningococcal population was less constant in genotype composition over time and was genetically less diverse during the peaks of the colonisation waves, and a smaller proportion of the isolates was nonserogroupable. We observed a broad age range in the healthy carriers, resembling that of meningitis patients during large disease epidemics. CONCLUSIONS: The observed lack of a temporally stable and genetically diverse resident pharyngeal flora of meningococci might contribute to the susceptibility to meningococcal disease epidemics of residents in the African meningitis belt. Because capsular conjugate vaccines are known to impact meningococcal carriage, effects on herd immunity and potential serogroup replacement should be monitored following the introduction of such vaccines.


Subject(s)
Meningococcal Infections/diagnosis , Meningococcal Infections/epidemiology , Adolescent , Adult , Age Factors , Child , Child, Preschool , Disease Outbreaks , Female , Ghana , Humans , Longitudinal Studies , Male , Meningococcal Infections/complications , Meningococcal Infections/microbiology , Middle Aged , Neisseria meningitidis/metabolism , Sex Factors
3.
Trop Med Int Health ; 10(12): 1229-34, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16359402

ABSTRACT

Neisseria meningitidis serogroup W135, well known for a long time as a cause of isolated cases of meningococcal meningitis, has recently increasingly been associated with disease outbreaks of considerable magnitude. Burkina Faso was hit by W135 epidemics in the dry seasons of 2002-2004, but only four W135 meningitis cases were recorded between February 2003 and March 2004 in adjoining Ghana. This reconfirms previous findings that bottlenecks exist in the spreading of new epidemic N. meningitidis clones within the meningitis belt of sub-Saharan Africa. Of the four Ghanaian W135 meningitis patients one died and three survived, of whom one had profound neurosensory hearing loss and speech impairment. All four disease isolates were sensitive to penicillin G, chloramphenicol, ciprofloxacin and cefotaxime and had the multi-locus sequence type (ST) 11, which is the major ST of the ET-37 clonal complex. Pulsed-field gel electrophoresis (PFGE) profiles of the Ghanaian disease isolates and recent epidemic isolates from Burkina Faso were largely identical. We conducted meningococcal colonization surveys in the home communities of three of the patients and in the Kassena Nankana District located at the border to Burkina Faso. W135 carriage rates ranged between 0% and 17.5%. When three consecutive surveys were conducted in the patient community with the highest carrier rate, persistence of W135 colonization over a period of 1 year was observed. Differences in PFGE profiles of carrier isolates taken at different times in the same patient community were indicative of rapid microevolution of the W135 bacteria, emphasizing the need for innovative fine typing methods to reveal the relationship between W135 isolates.


Subject(s)
Disease Outbreaks , Meningitis, Meningococcal/epidemiology , Neisseria meningitidis, Serogroup W-135/isolation & purification , Adolescent , Age Distribution , Anti-Bacterial Agents/therapeutic use , Biodiversity , Child , Child, Preschool , Electrophoresis, Gel, Pulsed-Field/methods , Female , Ghana/epidemiology , Humans , Male , Meningitis, Meningococcal/drug therapy , Meningitis, Meningococcal/microbiology , Neisseria meningitidis, Serogroup W-135/drug effects , Neisseria meningitidis, Serogroup W-135/genetics , Prevalence
4.
J Infect Dis ; 192(2): 192-9, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15962213

ABSTRACT

BACKGROUND: The Kassena-Nankana District (KND) of northern Ghana lies in the African meningitis belt, where epidemics of bacterial meningitis have been reoccurring every 8-12 years. These epidemics are generally caused by Neisseria meningitidis, an organism that is considered to be uniquely capable of causing meningitis epidemics. METHODS: We recruited all patients with suspected meningitis in the KND between 1998 and 2003. Cerebrospinal fluid samples were collected and analyzed by standard microbiological techniques. Bacterial isolates were subjected to serotyping, multilocus sequence typing (MLST), and antibiotic-resistance testing. RESULTS: A continual increase in the incidence of pneumococcal meningitis was observed from 2000 to 2003. This outbreak exhibited strong seasonality, a broad host age range, and clonal dominance, all of which are characteristic of meningococcal meningitis epidemics in the African meningitis belt. The case-fatality rate for pneumococcal meningitis was 44.4%; the majority of pneumococcal isolates were antibiotic sensitive and expressed the serotype 1 capsule. MLST revealed that these isolates belonged to a clonal complex dominated by sequence type (ST) 217 and its 2 single-locus variants, ST303 and ST612. CONCLUSIONS: The S. pneumoniae ST217 clonal complex represents a hypervirulent lineage with a high propensity to cause meningitis, and our results suggest that this lineage might have the potential to cause an epidemic. Serotype 1 is not included in the currently licensed pediatric heptavalent pneumococcal vaccine. Mass vaccination with a less complex conjugate vaccine that targets hypervirulent serotypes should, therefore, be considered.


Subject(s)
Meningitis, Bacterial/epidemiology , Meningococcal Infections/epidemiology , Neisseria meningitidis , Pneumococcal Infections/epidemiology , Drug Resistance, Bacterial , Ghana/epidemiology , Humans , Incidence , Meningococcal Infections/diagnosis , Microbial Sensitivity Tests , Neisseria meningitidis/classification , Neisseria meningitidis/drug effects , Pneumococcal Infections/diagnosis , Rain , Seasons , Serotyping , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects
5.
Phytother Res ; 17(3): 274-5, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12672160

ABSTRACT

In a continuing search for compounds with antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA) possessing multidrug ef flux systems, we have demonstrated activity associated with extracts from Southern prickly ash bark, Zanthoxylum clava-herculis. Bioassay-guided isolation of an alkaloid extract led to the characterization of the benzo[c]phenanthridine alkaloid chelerythrine as the major active principle. This compound exhibited potent activity against strains of MRSA, which were highly resistant to clinically useful antibiotics via multidrug ef flux mechanisms.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple , Methicillin Resistance , Phytotherapy , Plant Extracts/pharmacology , Staphylococcus aureus/drug effects , Zanthoxylum , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Dose-Response Relationship, Drug , Humans , Plant Bark , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...